Kazia Therapeutics Ltd ADR
- KZIA
- NASDAQ
- Biotechnology
- Oncology Drugs
- PI3K Inhibitor
- Clinical-Stage Biotech
$7.85
Today +8.28%Quote Oct 19, 2026, 08:00 PM UTC
−24.45%over the last month
Max drawdown −37.8%From 1-month high −28.1%3 months −44.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Kazia Therapeutics Ltd ADR
Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
6
Founded
1994
Market value
$24.5M
Approximate share count
Floor
$7.61
3.1% below price
Resistance
$8.75
11.4% above price
Price vs analyst targets
3 analysts
Lowest target
$29.00Highest target
$40.00
$29.00Highest target
$40.00
- Price $7.85
- Average target $33.67
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 329% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about KZIAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free